Apeiron Capital
$156M 13F equity value
21 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Apeiron Capital covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| MUU | DIREXION DAILY MU BULL 2X ET | 34,000 | $36M | 22.9% |
| ONON | ON HOLDING AG-CLASS A | 795,852 | $28M | 18.1% |
| ABVX | ABIVAX SA-ADR | 130,600 | $17M | 11.2% |
| QFIN | QFIN HOLDINGS INC-ADR | 976,185 | $15M | 9.9% |
| SMMT | SUMMIT THERAPEUTICS INC | 961,866 | $14M | 9.0% |
| TSM | TAIWAN SEMICONDUCTOR-SP ADR | 17,900 | $9M | 5.5% |
| WDC | WESTERN DIGITAL CORP | 13,000 | $8M | 5.3% |
| NKTR | NEKTAR THERAPEUTICS | 106,431 | $7M | 4.8% |
| NOK | NOKIA CORP-SPON ADR | 378,500 | $5M | 3.2% |
| STX | SEAGATE TECHNOLOGY HOLDINGS | 5,000 | $5M | 3.1% |
Track Apeiron Capital's 13F portfolio: $156M in reported holdings, 21 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}